Remote administration of hyaluronic acid to mammals
CA 1314218 C · Owner: Brown, Karen K. · Inventors: Brown, Karen K.; Wollen, Terry S.; Mozier, John O.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Mo-2817, REMOTE ADMINISTRATION OF HYALURONIC ACID TO MAMMALS ABSTRACT OF THE DISCLOSURE, The present disclosure is concerned with the discovery that hyaluronic acid, an agent well known to reduce the sequelae of trauma in mammalian joint tissue when applied directly to the traumatized tissue will be, carried to such traumatized tissue by the mammal's natural processes if applied at a site remote from the traumatized tissue. Thus, hyaluronic acid in any, therapeutically acceptable form can be administered by, the typical remote routes including intravenous intramuscular, subcutaneous and topical. This makes the utilization of hyaluronic acid much more convenient and attractive. For instance …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted March 9, 1993. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended March 9, 2010.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.